|
RBM18 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.16493489801906E-14 |
| Normal-vs-Stage2 |
7.98520000000469E-05 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
7.733600E-01 |
| Stage1-vs-Stage3 |
2.7298000000453E-06 |
| Stage1-vs-Stage4 |
4.13120000000156E-05 |
| Stage2-vs-Stage3 |
1.478440E-02 |
| Stage2-vs-Stage4 |
1.524040E-02 |
| Stage3-vs-Stage4 |
9.232800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.62525548574877E-12 |
| Normal-vs-Asian |
3.942300E-02 |
| Caucasian-vs-AfricanAmerican |
1.668950E-01 |
| Caucasian-vs-Asian |
1.996000E-01 |
| AfricanAmerican-vs-Asian |
4.860200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.62492241884138E-12 |
| Male-vs-Female |
4.556000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.30020003044729E-09 |
| Normal-vs-Age(41-60Yrs) |
2.66453525910038E-15 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
3.38870043137263E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.006600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.847800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.302400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.134400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.482800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.425200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.944900E-03 |
| Normal-vs-Grade 2 |
2.89068768921652E-12 |
| Normal-vs-Grade 3 |
1.62436730732907E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
4.029000E-01 |
| Grade 1-vs-Grade 3 |
6.035400E-03 |
| Grade 1-vs-Grade 4 |
5.379900E-04 |
| Grade 2-vs-Grade 3 |
2.24919999999296E-05 |
| Grade 2-vs-Grade 4 |
4.39559999954042E-07 |
| Grade 3-vs-Grade 4 |
1.000300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.70440003724559E-10 |
| Normal-vs-ccB subtype |
<1E-12 |
| ccA subtype-vs-ccB subtype |
4.83600000000806E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
7.85260001467947E-09 |
| N0-vs-N1 |
2.190600E-01 |
|
|
